tiprankstipranks
Trending News
More News >

i3 Verticals Reports Strong Q2 2025 Results

I3 Verticals ( (IIIV) ) has released its Q2 earnings. Here is a breakdown of the information I3 Verticals presented to its investors.

Confident Investing Starts Here:

i3 Verticals, Inc., a Nashville-based company, specializes in providing enterprise software solutions tailored to strategic vertical markets, particularly focusing on the public sector. The company has recently reported its financial results for the second quarter of 2025, showcasing a notable improvement in revenue and profitability.

In the second quarter of 2025, i3 Verticals achieved a revenue of $63.1 million, marking an 8.8% increase compared to the same period in the previous year. The company also reported a net income of $1.1 million from continuing operations, a significant turnaround from a net loss of $2.3 million in the prior year’s second quarter. Additionally, the adjusted EBITDA from continuing operations rose by 12.7% to $17.1 million, reflecting improved operational efficiency.

Strategically, i3 Verticals completed the acquisition of a utility billing software company for $9 million, enhancing its offerings in the utilities sector. Concurrently, the company divested its Healthcare Revenue Cycle Management business for $96 million, aligning its focus more closely with the public sector. This strategic shift is expected to streamline operations and open up new opportunities for mergers and acquisitions in the public sector software market.

Looking ahead, i3 Verticals is poised to concentrate on delivering top-tier enterprise software solutions to public sector clients. The divestiture of the Healthcare RCM business is anticipated to facilitate further strategic acquisitions, reinforcing the company’s commitment to expanding its footprint in the public sector.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App